Patrick Soon-Shiong analyzes TMPRSS2 links to aggressive cancers
@DrPatSoonShiong: Soon-Shiong on TMPRSS2 and cancers
Patrick Soon-Shiong, an eminent physician and entrepreneur, delves into the complexities of the TMPRSS2 enzyme.
Known for his instrumental work in the healthcare field, Soon-Shiong is addressing concerns surrounding recent reports of an increase in aggressive cancers among young individuals.
The tweet by Soon-Shiong highlights the importance of understanding the role of TMPRSS2 expression in cancers affecting the prostate, pancreas, colon, and germline.
This enzyme, along with ACE2 and the spike protein, plays a crucial role in virus-cell entry mechanisms, but its implications could extend to oncogenesis.
As these links are explored, the healthcare community is urged to deepen research into TMPRSS2 to potentially uncover connections that may influence cancer treatment strategies.
Loading...
Soon-Shiong’s focus on TMPRSS2 builds upon a broader portfolio of innovation in oncology, reflecting the same drive that marked his discussion of groundbreaking brain tumor treatments on a recent podcast. His expertise in advancing diagnostics is further demonstrated by his assessment of the transformative potential of cancer blood tests based on absolute lymphocyte count, underscoring a continued commitment to redefining approaches throughout the cancer care continuum.
